GemPharmatech Co., Ltd. (SHA:688046)

GemPharmatech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,386	5,249	8,262	9,861	-	-
Market Cap Growth	67.43%	-36.46%	-16.22%	-	-	-
Enterprise Value	6,416	4,152	7,195	8,681	-	-
Last Close Price	18.06	12.75	19.68	23.44	-	-
PE Ratio	71.69	47.80	51.99	59.88	-	-
Forward PE	57.03	23.62	36.05	40.76	-	-
PS Ratio	10.24	7.64	13.28	19.09	-	-
PB Ratio	3.41	2.46	3.89	4.99	-	-
P/TBV Ratio	3.48	2.52	3.98	5.11	-	-
P/OCF Ratio	49.53	58.12	70.87	93.04	-	-
EV/Sales Ratio	8.90	6.05	11.56	16.81	-	-
EV/EBITDA Ratio	36.62	25.22	45.71	63.98	-	-
EV/EBIT Ratio	70.53	45.22	64.57	88.23	-	-
Debt / Equity Ratio	0.14	0.06	0.06	0.01	0.03	0.01
Debt / EBITDA Ratio	1.77	0.75	0.74	0.13	0.20	0.05
Debt / FCF Ratio	8.28	-	-	-	1.04	-
Asset Turnover	0.27	0.27	0.26	0.31	0.41	0.39
Inventory Turnover	4.72	5.16	4.20	3.78	4.27	4.97
Quick Ratio	3.13	4.41	4.35	6.55	3.43	4.12
Current Ratio	3.28	4.61	4.52	6.85	3.69	4.33
Return on Equity (ROE)	4.88%	5.16%	7.75%	11.92%	17.32%	15.57%
Return on Assets (ROA)	2.10%	2.23%	2.88%	3.72%	6.22%	8.63%
Return on Capital (ROIC)	2.40%	2.54%	3.28%	4.38%	8.18%	11.67%
Return on Capital Employed (ROCE)	4.00%	4.20%	5.00%	4.80%	11.20%	12.80%
Earnings Yield	1.41%	2.09%	1.92%	1.67%	-	-
FCF Yield	0.51%	-0.45%	-1.08%	-0.85%	-	-
Dividend Yield	0.78%	1.10%	0.81%	0.18%	-	-
Payout Ratio	77.49%	72.95%	11.24%	0.17%	0.54%	0.88%
Buyback Yield / Dilution	-2.51%	0.18%	-3.93%	-9.84%	1.93%	-
Total Shareholder Return	-1.74%	1.28%	-3.12%	-9.67%	1.93%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.